File Download
 
 
Supplementary

Conference Paper: Persistence of pharmacological treatment into adulthood for ADHD patients who started treatment in childhood or adolescence in UK primary care
  • Basic View
  • Metadata View
  • XML View
TitlePersistence of pharmacological treatment into adulthood for ADHD patients who started treatment in childhood or adolescence in UK primary care
 
AuthorsMcCarthy, S
Wilton, L
Murray, M
Hodgkins, P
Asherson, P
Wong, ICK
 
Issue Date2012
 
CitationThe 2nd European Network of Hyperkinetic Disorders (EUNETHYDIS) International ADHD Congress, Barcelona, Spain, 23-25 May 2012, p. 318 [How to Cite?]
 
DescriptionEUNETHYDIS 2012 entitled: Sharpening the cutting edge of ADHD science and clinical practice
 
DC FieldValue
dc.contributor.authorMcCarthy, S
 
dc.contributor.authorWilton, L
 
dc.contributor.authorMurray, M
 
dc.contributor.authorHodgkins, P
 
dc.contributor.authorAsherson, P
 
dc.contributor.authorWong, ICK
 
dc.date.accessioned2012-09-20T08:21:11Z
 
dc.date.available2012-09-20T08:21:11Z
 
dc.date.issued2012
 
dc.descriptionEUNETHYDIS 2012 entitled: Sharpening the cutting edge of ADHD science and clinical practice
 
dc.identifier.citationThe 2nd European Network of Hyperkinetic Disorders (EUNETHYDIS) International ADHD Congress, Barcelona, Spain, 23-25 May 2012, p. 318 [How to Cite?]
 
dc.identifier.epage318
 
dc.identifier.hkuros207289
 
dc.identifier.spage318
 
dc.identifier.urihttp://hdl.handle.net/10722/165606
 
dc.languageeng
 
dc.relation.ispartofEUNETHYDIS 2nd International ADHD Congress 2012
 
dc.titlePersistence of pharmacological treatment into adulthood for ADHD patients who started treatment in childhood or adolescence in UK primary care
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>McCarthy, S</contributor.author>
<contributor.author>Wilton, L</contributor.author>
<contributor.author>Murray, M</contributor.author>
<contributor.author>Hodgkins, P</contributor.author>
<contributor.author>Asherson, P</contributor.author>
<contributor.author>Wong, ICK</contributor.author>
<date.accessioned>2012-09-20T08:21:11Z</date.accessioned>
<date.available>2012-09-20T08:21:11Z</date.available>
<date.issued>2012</date.issued>
<identifier.citation>The 2nd European Network of Hyperkinetic Disorders (EUNETHYDIS) International ADHD Congress, Barcelona, Spain, 23-25 May 2012, p. 318</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/165606</identifier.uri>
<description>EUNETHYDIS 2012 entitled: Sharpening the cutting edge of ADHD science and clinical practice</description>
<language>eng</language>
<relation.ispartof>EUNETHYDIS 2nd International ADHD Congress 2012</relation.ispartof>
<title>Persistence of pharmacological treatment into adulthood for ADHD patients who started treatment in childhood or adolescence in UK primary care</title>
<type>Conference_Paper</type>
<identifier.hkuros>207289</identifier.hkuros>
<identifier.spage>318</identifier.spage>
<identifier.epage>318</identifier.epage>
</item>